$KRMD News

KORU Medical Systems Selloff Offers An Opportunity

KORU (KRMD) Q2 2026 Earnings Call Transcript

KORU Medical Systems Inc (KRMD) (Q2 2026) Earnings Call Highlights: Record Revenue and First ...

KORU Medical Systems Q2 Earnings Call Highlights

KORU Medical Systems, Inc. Q2 2026 Earnings Call Summary

Koru Medical Systems (NASDAQ:KRMD) Slips on Full-Year Revenue Guidance Cut and U.S. Oncology Strategic Pivot

KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call Transcript

KORU Medical Systems, Inc. 2026 Q2 - Results - Earnings Call Presentation

KORU Medical Systems, Inc. (KRMD) Q2 Earnings and Revenues Beat Estimates

KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance

Koru Medical Systems Withdraws 510(K) Application For FreedomEDGE With Phesgo In U.S. To Focus On Alternative Higher Volume Molecules

KORU Medical Systems Narrows FY2026 Sales Guidance from $47.500M-$50.000M to $47.500M-$48.500M vs $48.688M Est

KORU Medical Systems Q2 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $12.045M Beat $11.609M Estimate

KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference

KORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026

KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress

KORU Medical Systems Presents Data Titled 'Reducing Ergonomic Strain During Subcutaneous Monoclonal Antibody Administration' At Oncology Nursing Society Congress

KORU Medical Systems, Inc. Q1 2026 Earnings Call Summary

KORU Medical Systems, Inc. (KRMD) Q1 2026 Earnings Call Transcript

KORU Medical Systems Q1 Earnings Call Highlights